CAD & Atherosclerosis
Conference Coverage
Oral PCSK9 inhibitor shows encouraging LDL lowering
A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.
From the Journals
Treat together: Tackle heart disease and obesity simultaneously
A new review outlines how obesity can impair common imaging tests used to diagnose heart disease.
Conference Coverage
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
Commentary
Three surprising studies on exercise restriction and an exercise sweet spot
New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.
From the Journals
Causal link found between childhood obesity and adult-onset diabetes
Bigger children have increased risks for almost all subtypes of adult-onset diabetes, a Mendelian randomization study indicates.
Conference Coverage
‘Keto-like’ diet linked to doubling of heart disease risk
But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.
Conference Coverage
In early days, bioabsorbable stent rivals nonabsorbable devices
Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.
20th Anniversary
20 years of clinical research in cardiology
“It’s unbelievable how much we’ve accomplished in the last 20 years” in cardiology, said Dr. Steven E. Nissen.
Conference Coverage
Heart-healthy actions promote longer, disease-free life
Stronger measures of cardiovascular health were linked to longer life expectancy and fewer chronic conditions.
Conference Coverage
High CV risk factor burden in young adults a ‘smoldering’ crisis
Cardiovascular risk factors are “unacceptably” high and are increasing among young adults, prompting calls for aggressive preventive measures.
Conference Coverage
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD